Lantern Pharma Inc. (LTRN) Financials
LTRN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 8.6 million | 11.8 million |
| March 31, 2026 | 7.2 million | 3.8 million |
| Dec. 31, 2025 | 11.0 million | 4.5 million |
| Sept. 30, 2025 | 13.6 million | 4.0 million |
LTRN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.9 million | 285260 |
| March 31, 2026 | -3.8 million | 262915 |
| Dec. 31, 2025 | -2.8 million | 198816 |
| Sept. 30, 2025 | -4.6 million | 143685 |
LTRN Net Income
No data available :(
LTRN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 7.4 million | - | - |
| March 31, 2026 | 6.3 million | - | 59076 |
| Dec. 31, 2025 | 10.1 million | - | 78539 |
| Sept. 30, 2025 | 12.4 million | - | 93954 |
LTRN Shares Outstanding
LTRN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 1.8 million | 1.7 million | - |
| March 31, 2026 | 3 | 1.7 million | 1.7 million | - |
| Dec. 31, 2025 | 1 | 2.7 million | 1.5 million | 115600 |
| Sept. 30, 2025 | 560 | 2.4 million | 1.9 million | - |
LTRN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 3853 |
| Dec. 31, 2025 | - | -4102 |
| Sept. 30, 2025 | - | 4102 |
LTRN
Price: $2.52
52 week price:
Earnings Per Share: -1.45 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2116
Market Capitalization: 33.9 million